Field-based 3D-QSAR studies on amide- and urea-containing NAMPT inhibitors
Chemometrics and Intelligent Laboratory Systems, ISSN: 0169-7439, Vol: 242, Page: 104984
2023
- 3Citations
- 4Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Nicotinamide phosphoribosyltransferase (NAMPT) is an important regulator enzyme in the mammalian NAD + synthesis pathway that catalyzes the condensation of nicotinamide (NAM) with 5-phosphoribosyl-1-pyrophosphate (PRPP) to produce nicotinamide mononucleotide (NMN). Considering NAD + is involved in many cellular processes like cytokine production, metabolism, and aging, resulting in NAMPT has been regarded as a therapeutically important target for various diseases, particularly cancer. Hence, numerous NAMPT inhibitors have been reported to date. However, the side effect profile of these inhibitors have sparked interest in discovering new molecules. Herein, statistically validated field-based 3D-QSAR models were constructed using chemically diverse amide- and urea-containing NAMPT inhibitors. The contour maps resulting from the best model (R 2 = 0.8412, Q 2 = 0.8464, Pearson-r = 0.9270) were exploited to get insight into structural properties related to NAMPT inhibition and the outcomes of field-based 3D-QSAR analysis appear that the steric interactions contributed to the activity more than electrostatic, hydrophobic, hydrogen bond acceptor (HBA), hydrogen bond donor (HBD), and aromatic ring fields.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0169743923002344; http://dx.doi.org/10.1016/j.chemolab.2023.104984; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85171557925&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S0169743923002344; https://dx.doi.org/10.1016/j.chemolab.2023.104984
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know